Condition
Bevacizumab clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Bevacizumab clinical trials that are recruiting, in China. By phase: Phase 2 (4), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 1Country
Newest Bevacizumab clinical trials
All recruiting trials (8)
-
Targeted FSRT plus bevacizumab versus hippocampus-sparing whole-brain radiation for people with lung adenocarcinoma that has spread to the brain
This will test whether focused 5-day fractionated stereotactic radiotherapy (FSRT) combined with bevacizumab works better than hippocampus-avoidant whole-brain radiotherapy with a simultaneous boost at controlling brain metastases and protecting memory in adults with lung adenocarcinoma and extensive brain metastases.
-
QL1706 with bevacizumab plus RALOX-HAIC for liver cancer with VP3/4 portal vein tumor thrombus
This trial will test whether giving QL1706 together with bevacizumab and RALOX hepatic arterial infusion chemotherapy helps people with hepatocellular carcinoma and VP3/4 portal vein tumor thrombosis live longer or shrink tumors.
-
Low-dose trifluridine/tipiracil plus bevacizumab for metastatic colorectal cancer
This will try a lower-dose trifluridine/tipiracil plus bevacizumab regimen for people with metastatic colorectal cancer who have progressed after at least two prior treatments.
-
Combining Befotertinib with Bevacizumab or Chemotherapy for Lung Cancer Treatment
This study is testing if a new lung cancer treatment combining befotertinib with either bevacizumab or chemotherapy can help patients with early-stage cancer that has an EGFR mutation feel better before surgery.
-
Combining dTACE-HAIC with Bevacizumab and Atezolizumab for treating large liver cancer
This study is testing a new combination treatment for people with large liver cancer to see if it works better than current options for those who can't have surgery.
-
Combining locoregional therapy with Bevacizumab and PD1/L1 inhibitors for advanced liver cancer
This study is testing if combining a local treatment with Bevacizumab and PD1/L1 inhibitors can help people with advanced liver cancer who can’t have surgery feel better and improve their outcomes.
-
Cryoablation with Cadonilimab and Bevacizumab for Liver Cancer with Lung Metastases
This study is testing if a new treatment that combines freezing liver tumors with two immunotherapy drugs can help patients with advanced liver cancer that has spread to the lungs feel better when other treatments haven't worked.
-
Treatment for advanced liver cancer using TACE with new medications
This study is testing a new treatment combining TACE with two medications to see if it helps people with advanced liver cancer who can't have surgery.
Related topics
Quick answers
How many Bevacizumab clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.